MedPath

Sodium Bicarbonate

Sodium Bicarbonate Injection, USP

Approved
Approval ID

09cf38c2-0b44-eca1-e063-6294a90a72d8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM BICARBONATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7310
Application NumberANDA211091
Product Classification
M
Marketing Category
C73584
G
Generic Name
SODIUM BICARBONATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 10, 2023
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BICARBONATEActive
Quantity: 84 mg in 1 mL
Code: 8MDF5V39QO
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Bicarbonate - FDA Drug Approval Details